Molecularly targeted therapy for metastatic cancer: The tumor suppressor miRNA Let-7c suppresses the expression of oncogenic RNA MALAT1 via up regulation of its target gene, 16/February/2014, 5.33 am
Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Molecularly targeted therapy for metastatic cancer: The tumor suppressor miRNA Let-7c suppresses the expression of oncogenic RNA MALAT1 via up regulation of its target gene, 16/February/2014, 5.33 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org
Molecularly targeted therapy for metastatic cancer: OCT4 suppresses the expression of oncogenic RNA MALAT1 via up regulation of its target gene, 16/February/2014, 5.29 am
Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Molecularly targeted therapy for metastatic cancer: OCT4 suppresses the expression of oncogenic RNA MALAT1 via up regulation of its target gene, 16/February/2014, 5.29 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org
Molecularly targeted therapy for metastatic cancer: CDX2 suppresses the expression of oncogenic RNA MALAT1 via up regulation of its target gene, 16/February/2014, 5.26 am
Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Molecularly targeted therapy for metastatic cancer: CDX2 suppresses the expression of oncogenic RNA MALAT1 via up regulation of its target gene, 16/February/2014, 5.26 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org
Insights into Cancer therapy: NOS-2 suppresses the expression of tumor suppressor KRIT1/CCM1 via up regulation of its target gene, 15/February/2014, 14.40
Noble Laureate in Medicine (1998) Prof. Dr Ferid (The University of Texas, Houston, Texas, USA) has suggested in a number of papers that inhibition of NOS2 (Nitric oxide synthase) may have a therapeutic value in a number of cancers. In connection with this finding, Dr L Boominathan, Director-cum-chief scientist of GBMD, reports that: Insights into Cancer therapy: NOS-2 suppresses the expression of tumor suppressor […]
Insights into Cancer therapy: NOS-2 suppresses the expression of tumor suppressor TPM1 via up regulation of its target gene, 15/February/2014, 14.35
Noble Laureate in Medicine (1998) Prof. Dr Ferid (The University of Texas, Houston, Texas, USA) has suggested in a number of papers that inhibition of NOS2 (Nitric oxide synthase) may have a therapeutic value in a number of cancers. In connection with this finding, Dr L Boominathan, Director-cum-chief scientist of GBMD, reports that: Insights into Cancer therapy: NOS-2 suppresses the […]
Tumorigenesis: JMJD3 suppresses the expression of tumor suppressor PTEN via up regulation of its target gene, 15/February/2014, 13.58
Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Tumorigenesis: JMJD3 suppresses the expression of tumor suppressor PTEN via up regulation of its target gene, 15/February/2014, 13.58, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org